A review and evaluation of doubly robust approaches for estimating average treatment effects
Clinical Snapshot
PICO Framework
| P — Population | Nonexperimental studies requiring covariate adjustment for treatment effect estimation |
| I — Intervention | Doubly robust methods (augmented inverse probability weighting, regression weighted by inverse propensity score, regression with inverse propensity score as covariate, calibrated propensity score weighting) |
| C — Comparator | Traditional methods (regression estimation and inverse probability weighting) |
| O — Outcomes | Bias reduction in average treatment effect estimates, protection against model misspecification |
Bottom Line
This methodological review demonstrates that doubly robust approaches offer superior protection against bias in estimating treatment effects from observational data compared to traditional regression or propensity score methods alone. The key advantage is that these methods remain unbiased if either the outcome model or propensity score model is correctly specified, providing a safety net against model misspecification. Regression weighted by inverse propensity score emerged as particularly robust across simulation scenarios. For Australian healthcare researchers conducting real-world effectiveness studies, pharmaceutical outcomes research, or health services evaluations, adopting doubly robust methods could significantly improve the reliability of treatment effect estimates. However, implementation requires careful attention to practical considerations including propensity score truncation, weight normalization, and potential efficiency losses. The methods are most valuable when there is uncertainty about model specification and when unbiased treatment effect estimation is critical for clinical or policy decisions.
Key Findings
P Value: Not reported
Effect Size: Doubly robust methods, particularly regression weighted by inverse propensity score, showed superior performance
Primary Outcome: Bias reduction in average treatment effect estimates
Nnt Or Sensitivity: Methods provide protection when either outcome model or propensity score model is correctly specified
Confidence Interval: Not applicable - simulation study
Clinical Application
Moderate - requires statistical expertise but methods are implementable with standard software Highly relevant for Australian health services research, pharmaceutical outcomes research, and real-world evidence studies required by TGA. Particularly valuable for PBS effectiveness evaluations and RACGP guideline development using observational data Researchers conducting observational studies to estimate treatment effects in healthcare settings
Abstract
In nonexperimental studies, obtaining an unbiased estimate of the average treatment effect (ATE) typically requires two key assumptions: that all relevant covariates are measured (i.e., no unmeasured confounding) and that the statistical model used for covariate adjustment is correctly specified. Two common approaches for adjustment are specifying an outcome model and propensity score weighting. To mitigate bias from model misspecification, doubly robust methods combine both approaches, ensuring unbiased ATE estimates if either the outcome model or the propensity score model is correctly specified. In this study, we review four doubly robust methods that have received considerable attention in the methodological literature but remain underutilized in psychological research: augmented inverse probability weighting, regression weighted by the inverse propensity score, regression incorporating the inverse propensity score as a covariate, and calibrated propensity score weighting. Using two simulation studies, we compare these methods with regression estimation and inverse probability weighting estimators. Our results suggest that doubly robust methods-particularly regression weighted by the inverse propensity score-offer greater protection against bias from model misspecification across various data-generating scenarios. We also discuss practical considerations for implementing doubly robust methods, including weight normalization, propensity score truncation, and potential efficiency losses due to overfitting. The different methods for estimating the ATE are illustrated in a data example.
References
- 1.Zhang, J., Lüdtke, O., & Robitzsch, A. (2026). A review and evaluation of doubly robust approaches for estimating average treatment effects. Behavior Research Methods. https://doi.org/10.1080/01621459.2015.1023805
Related Research
Current pain and headache reports
Chronic Pain and the Risk of Dementia: A Systematic Review and Meta-Analysis
23 July 2026
Reviews on environmental health
Air quality and public health co-benefits of national transport policies
25 June 2026
Journal of affective disorders
Prediction models for suicide reattempts by lasso regression through machine learning models: Single versus multiple suicide attempters.
16 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service